ZITO MARINO, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 5.636
NA - Nord America 2.536
AS - Asia 2.362
SA - Sud America 376
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 51
OC - Oceania 4
Totale 11.185
Nazione #
RU - Federazione Russa 3.835
US - Stati Uniti d'America 2.451
SG - Singapore 757
IT - Italia 567
IE - Irlanda 555
HK - Hong Kong 447
CN - Cina 446
BR - Brasile 324
VN - Vietnam 304
DE - Germania 177
GB - Regno Unito 142
KR - Corea 135
JP - Giappone 99
UA - Ucraina 82
IN - India 63
CA - Canada 62
FR - Francia 53
GR - Grecia 44
FI - Finlandia 39
AT - Austria 22
TR - Turchia 22
NL - Olanda 21
SE - Svezia 21
AR - Argentina 16
MX - Messico 15
ZA - Sudafrica 15
BE - Belgio 14
PK - Pakistan 12
PL - Polonia 12
CH - Svizzera 11
BD - Bangladesh 10
IQ - Iraq 10
MA - Marocco 10
ES - Italia 9
PH - Filippine 9
EC - Ecuador 7
PY - Paraguay 7
CO - Colombia 6
MK - Macedonia 6
VE - Venezuela 6
BJ - Benin 5
CL - Cile 5
CZ - Repubblica Ceca 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
ID - Indonesia 4
SA - Arabia Saudita 4
TN - Tunisia 4
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
PA - Panama 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 10.966
Città #
Moscow 1.456
Dublin 551
Hong Kong 443
San Jose 399
Singapore 374
Santa Clara 332
Chandler 263
Ashburn 161
Naples 149
Seoul 134
Jacksonville 132
Ho Chi Minh City 99
Beijing 78
Hanoi 73
Princeton 67
Roxbury 67
Dallas 57
Munich 57
Hefei 54
New York 49
Bremen 46
Bengaluru 41
Los Angeles 38
Medford 38
Elora 37
Council Bluffs 35
São Paulo 34
Aversa 33
Cambridge 29
The Dalles 29
Caserta 26
Des Moines 23
Da Nang 21
Ercolano 21
Nuremberg 21
Wilmington 19
Napoli 18
Boardman 17
Brussels 14
Haiphong 14
Orem 14
Brooklyn 13
Memphis 12
San Francisco 12
Warsaw 12
Biên Hòa 11
Grumo Nevano 11
Rome 11
Ninh Bình 10
Tokyo 10
Vienna 10
Woodbridge 10
Amsterdam 9
Falkenstein 9
Frankfurt am Main 9
Rio de Janeiro 9
Atlanta 8
Brasília 8
Chicago 8
Helsinki 8
Johannesburg 8
Lappeenranta 8
Milan 8
Seattle 8
Shanghai 8
Stockholm 8
Columbus 7
Düsseldorf 7
Montreal 7
Portici 7
Tianjin 7
Afragola 6
Ann Arbor 6
Asunción 6
Belo Horizonte 6
Chennai 6
Mexico City 6
Nanchang 6
Thái Nguyên 6
Volla 6
Ariano Irpino 5
Castellammare di Stabia 5
Changsha 5
Curitiba 5
Falls Church 5
Goiânia 5
Guangzhou 5
Hải Dương 5
Jinan 5
London 5
San Giuliano 5
Tashkent 5
Toronto 5
Turku 5
Baku 4
Boydton 4
Bắc Ninh 4
Bến Tre 4
Hangzhou 4
Houston 4
Totale 5.984
Nome #
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 197
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 188
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 182
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 180
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 176
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 165
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 165
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 163
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 163
Cytologic diagnosis of metastatic melanoma by FNA: A practical review 161
A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS-The Experience in Pathological Anatomy Unit 160
Predictive biomarkers along gastric cancer pathogenetic pathways 154
AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma 152
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 151
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 151
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy 150
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 150
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond 146
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 146
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers 146
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 145
Interventional cytopathology in COVID-19 ERA 145
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 144
A new look at the ALK gene in cancer: copy number gain and amplification 139
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 137
To Get the Most out of the Least: BRAF Molecular Evaluation in Melanoma Metastases on Cell Suspension from Fine Needle Aspiration Cytology Needle Rinses 136
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 136
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 136
Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies 136
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors 135
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 135
HER2 EXPRESSION IN GASTROINTESTINAL TUMOR. A FOCUS ON DIAGNOSTIC ALGORITHM OF HER2. STATUS FROM GASTRIC TO INTESTINAL CANCER 134
GOLPH3 promotes oncogenesis by controlling the intra-Golgi trafficking of glycosphingolipid synthases 134
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 131
AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma 131
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 131
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 130
Correction: Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 130
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 128
Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method 127
Concomitant ALK/KRAS and ALK/EGFR mutations in non small cell lung cancer: Different profile of response to target therapies 125
Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods 124
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples 123
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC 122
MALT GASTRIC LYMPHOMA: AN UPDATE OF PATHOGENETIC FEATURES 121
Second Diagnostic Opinion by Experienced Dermatopathologists in the Setting of a Referral Regional Melanoma Unit Significantly Improves the Clinical Management of Patients With Cutaneous Melanoma 121
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 120
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 117
Mesenchymal neoplasms: Is it time for cytology? New perspectives for the pre-operative diagnosis of soft tissue tumors in the molecular era 117
Diagnostic accuracy of FNA cytology for diagnosis of salivary gland tumors in pediatric patients 116
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems 115
The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules 113
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 113
Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features 113
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 112
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 112
Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients 112
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 111
Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features 109
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV 109
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas 108
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 107
COVID-19: detection methods in post-mortem samples 106
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 106
New therapeutic perspectives in CCDC6 deficient lung cancer cells 103
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 103
CRISPR-barcoding in non small cell lung cancer: From intratumor genetic heterogeneity modeling to cancer therapy application 103
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 103
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis 101
How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls 100
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 100
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS 98
Mitochondrial AKAP1 supports mTOR pathway and tumor growth 98
Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features 98
Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma 97
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era 95
The GOLPH3 oncogene controls the intra-Golgi recycling of sphingolipid glycosylating enzymes to promote proliferation 94
Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks 92
Nivolumab in heavily pretreated metastatic gastric cancer patients: Real-life data from a western population 92
Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy 90
Immunohistochemistry for cancer stem cells detection: Principles and methods 87
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer 86
The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 84
RNAScope in situ Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor 80
NTRK Gene Fusion Detection in Atypical Spitz Tumors 80
Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors 77
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multi-institutional research study 71
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 71
Detection of ROSI rearrangement in non-small cell lung cancer: Current and future perspectives 70
Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples 52
The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism 50
Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma 48
MTAP in small biopsy samples of pancreatic lesions: a potential diagnostic biomarker. Immunohistochemical, fluorescence in situ hybridization and molecular analysis 25
Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology 24
BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samples 15
Totale 11.185
Categoria #
all - tutte 40.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022481 0 12 3 4 126 7 30 10 22 48 75 144
2022/20231.093 128 36 20 87 99 80 11 52 524 14 18 24
2023/2024502 44 27 25 33 145 41 20 17 12 11 45 82
2024/20251.686 24 19 12 34 301 235 268 174 232 193 124 70
2025/20266.639 285 396 296 288 555 3.568 365 317 206 202 110 51
2026/2027132 53 79 0 0 0 0 0 0 0 0 0 0
Totale 11.185